AAAAAA
Results:
1-9
|
Results: 9
Authors:
Dusinska, M
Ficek, A
Horska, A
Raslova, K
Petrovska, H
Vallova, B
Drlickova, M
Wood, SG
Stupakova, A
Gasparovic, J
Bobek, P
Nagyova, A
Kovacikova, Z
Blazicek, P
Liegebel, U
Collins, AR
Citation: M. Dusinska et al., Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans, MUT RES-F M, 482(1-2), 2001, pp. 47-55
Authors:
Dobiasova, M
Raslova, K
Rauchova, H
Vohnout, B
Ptackova, K
Frohlich, J
Citation: M. Dobiasova et al., Atherogenic lipoprotein profile in families with and without history of early myocardial infarction, PHYSL RES, 50(1), 2001, pp. 1-8
Authors:
Vohnout, B
Raslova, K
Gasparovic, J
Donati, MB
Iacoviello, L
Citation: B. Vohnout et al., Familial hypercholesterolaemia, LANCET, 357(9269), 2001, pp. 1712-1712
Authors:
Raslova, K
Smolkova, B
Vohnout, B
Gasparovic, J
Frohlich, JJ
Citation: K. Raslova et al., Risk factors for atherosclerosis in survivors of myocardial infarction andtheir spouses: Comparison to controls without personal and family history of atherosclerosis, METABOLISM, 50(1), 2001, pp. 24-29
Authors:
Raslova, K
Nagyova, A
Dobiasova, M
Ptackova, K
Dusinska, M
Citation: K. Raslova et al., Effect of ciprofibrate on lipoprotein metabolism and oxidative stress parameters in patients with type 2 diabetes mellitus and atherogenic lipoprotein phenotype, ACT DIABETO, 37(3), 2000, pp. 131-134
Authors:
Raslova, K
Bederova, A
Gasparovic, J
Blazicek, P
Smolkova, B
Citation: K. Raslova et al., Effect of diet and 677 C -> T 5, 10-methylenetetrahydrofolate reductase genotypes on plasma homocyst(e)ine concentrations in Slovak adolescent population, PHYSL RES, 49(6), 2000, pp. 651-658
Authors:
Nagyova, A
Sustrova, M
Raslova, K
Citation: A. Nagyova et al., Serum lipid resistance to oxidation and uric acid levels in subjects with Down's syndrome, PHYSL RES, 49(2), 2000, pp. 227-231
Authors:
Nagyova, A
Sustrova, M
Raslova, K
Citation: A. Nagyova et al., Plasma lipid and lipoprotein levels and LDL oxidation in subjects with Down syndrome, BIOLOGIA, 54(6), 1999, pp. 719-723
Authors:
Raslova, K
Dobiasova, M
Nagyova, A
Fabry, R
Rauchova, H
Dusinska, M
Citation: K. Raslova et al., Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype:effects on HDL quality, LDL susceptibility to oxidation and DNA damage, EUR J CL PH, 54(9-10), 1998, pp. 697-699
Risultati:
1-9
|